NKX3-2 | NK3 homeobox 2 | Disease related genes Transcription factors
| ![](/images/27564/ihc_selected_60x60.jpg) | ![](/images/27564/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27564/59934_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
NPY1R | Neuropeptide Y receptor Y1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/29903/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29903/64097_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
NPY5R | Neuropeptide Y receptor Y5 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/13790/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13790/31772_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
NTN4 | Netrin 4 | Cancer-related genes Predicted secreted proteins
| ![](/images/49832/ihc_selected_60x60.jpg) | ![](/images/49832/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49832/110313_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49047/111260_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY6 | Pyrimidinergic receptor P2Y, G-protein coupled, 6 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/22740/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22740/54854_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
PARP15 | Poly (ADP-ribose) polymerase family, member 15 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PCDH17 | Protocadherin 17 | Predicted membrane proteins
| ![](/images/26817/ihc_selected_60x60.jpg) | ![](/images/26817/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26817/55532_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PCSK6 | Proprotein convertase subtilisin/kexin type 6 | Enzymes
| ![](/images/4774/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4774/13935_B_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
PDE6G | Phosphodiesterase 6G, cGMP-specific, rod, gamma | Disease related genes Enzymes Potential drug targets
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PF4V1 | Platelet factor 4 variant 1 | Plasma proteins Predicted secreted proteins
| ![](/images/52485/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52485/126145_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
PITPNM3 | PITPNM family member 3 | Disease related genes
| | ![](/images/59005/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22432/133053_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
PKD2L1 | Polycystic kidney disease 2-like 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/22621/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22621/49685_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
PRF1 | Perforin 1 (pore forming protein) | Cancer-related genes Disease related genes Predicted secreted proteins
| ![](/images/2436/ihc_selected_60x60.jpg) | ![](/images/37940/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2436/6380_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins
| | ![](/images/40923/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40944/90010_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PTCRA | Pre T-cell antigen receptor alpha | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PTGER1 | Prostaglandin E receptor 1 (subtype EP1), 42kDa | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43734/97692_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
RENBP | Renin binding protein | Enzymes
| | | ![](/images/428/ihc_cell_selected_60x60.jpg) | ![](/images/522/904_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
RGS18 | Regulator of G-protein signaling 18 | | ![](/images/45780/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45780/105490_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
RGS19 | Regulator of G-protein signaling 19 | | ![](/images/31925/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/31925/ihc_cell_selected_60x60.jpg) | ![](/images/31925/68982_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
RP11-599B13.6 | Uncharacterized protein | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
S1PR4 | Sphingosine-1-phosphate receptor 4 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/60601/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60601/136482_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
SAP25 | Sin3A-associated protein, 25kDa | | ![](/images/62610/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/62610/ihc_cell_selected_60x60.jpg) | ![](/images/62610/140278_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| ![](/images/6117/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6117/19046_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/36746/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36746/78169_A_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
SEMA3D | Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D | | ![](/images/37522/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37522/73641_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
SH2D1B | SH2 domain containing 1B | | ![](/images/54791/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54791/135240_A_3_1_rna_selected_60x60.jpg) | Tissue enhanced |
SHANK3 | SH3 and multiple ankyrin repeat domains 3 | | | ![](/images_static/na_center.gif) | ![](/images/3446/ihc_cell_selected_60x60.jpg) | ![](/images/3446/11715_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC12 | Sialic acid binding Ig-like lectin 12 (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14377/33569_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC5 | Sialic acid binding Ig-like lectin 5 | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24900/57350_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC5 | | Predicted membrane proteins
| ![](/images/9085/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9085/24131_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC7 | Sialic acid binding Ig-like lectin 7 | CD markers Predicted membrane proteins Predicted secreted proteins
| ![](/images/25154/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25154/59907_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted membrane proteins Transporters
| | ![](/images/41329/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41004/90176_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
SNTG1 | Syntrophin, gamma 1 | Cytoskeleton related proteins Plasma proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
TAC1 | Tachykinin, precursor 1 | Predicted secreted proteins
| ![](/images/14429/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14429/34532_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30043/70681_A_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
TCHH | Trichohyalin | Cytoskeleton related proteins Plasma proteins
| ![](/images/28375/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28375/61897_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
TDGF1 | Teratocarcinoma-derived growth factor 1 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
TLX1NB | TLX1 neighbor | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
TMC8 | Transmembrane channel-like 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/54429/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54429/123803_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM26 | Transmembrane protein 26 | Predicted membrane proteins
| ![](/images/14350/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14350/33090_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
TNFRSF13B | Tumor necrosis factor receptor superfamily, member 13B | CD markers Disease related genes Predicted membrane proteins
| ![](/images/30453/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30453/66962_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
TTC24 | Tetratricopeptide repeat domain 24 | | ![](/images/29799/ihc_selected_60x60.jpg) | ![](/images/29799/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/29799/64512_B_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
TUBB1 | Tubulin, beta 1 class VI | Disease related genes FDA approved drug targets Plasma proteins
| ![](/images/43640/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4286/11724_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
UNC13A | Unc-13 homolog A (C. elegans) | | ![](/images/41418/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41418/89088_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
VCAM1 | Vascular cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5426/18356_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
VMO1 | Vitelline membrane outer layer 1 homolog (chicken) | Predicted secreted proteins
| ![](/images/23038/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23038/103495_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
WDR86 | WD repeat domain 86 | | ![](/images/21086/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21086/47380_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |